Systemic to pulmonary arterial shunts are surgically created connections between the aorta and a pulmonary artery in children with cyanotic congenital heart disease, such as tetralogy of Fallot or ...

We previously reported on the partial prevention of experimental shunt-induced pulmonary arterial hypertension (PAH) by the nonselective endothelin (ET) ET-A/ET-B receptor antagonist bosentan. As the ...

Pulmonary vascular function is impaired with increased pulmonary blood flow (PBF). We hypothesized that a peroxisome proliferator–activated receptor-γ (PPAR-γ) agonist would mitigate this effect. An ...

A patient with pulmonary arterial hypertension (PAH) who received a modified Potts shunt exhibited improved quality of life and exercise capacity after 1 year. A case report published in ERJ Open ...

Among patients with advanced chronic obstructive pulmonary disease (COPD), an arteriovenous (AV) shunt improves physiological parameters such as cardiac output and oxygen delivery but does not have a ...

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — A transcatheter interatrial shunt device reduced pulmonary capillary wedge pressure during ...

Congenital heart defects (CHDs) are among the top eight causes of infant mortality worldwide. Annually, CHDs affect around 40,000 infants in the United States, with approximately one in four having a ...

VENOUS anastomoses connecting the portal and pulmonary veins have been shown in cirrhotic patients by post-mortem injection, 1 and there has been considerable speculation concerning their possible ...

Please provide your email address to receive an email when new articles are posted on . “Dyspnea due to left atrial pressure overload during exercise is a hallmark of heart failure with preserved or ...

The characteristics of hepatopulmonary syndrome include an oxygen saturation < 80%, an increased alveolar-arterial gradient (> 15 mm Hg) while breathing room air, portal hypertension with or without ...